1. Home
  2. COCP vs BESS Comparison

COCP vs BESS Comparison

Compare COCP & BESS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.18

Market Cap

21.6M

Sector

Health Care

ML Signal

HOLD

Logo Bimergen Energy Corporation Common Stock

BESS

Bimergen Energy Corporation Common Stock

N/A

Current Price

$2.75

Market Cap

21.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
COCP
BESS
Founded
2006
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
21.6M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
COCP
BESS
Price
$1.18
$2.75
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
54.9K
53.9K
Earning Date
05-15-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
54.65
N/A
EPS
N/A
N/A
Revenue
$12,712,091.00
$168,880.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$2.00
52 Week High
$2.03
$6.45

Technical Indicators

Market Signals
Indicator
COCP
BESS
Relative Strength Index (RSI) 55.04 41.17
Support Level $0.91 $2.55
Resistance Level $1.22 $3.17
Average True Range (ATR) 0.07 0.22
MACD 0.00 -0.01
Stochastic Oscillator 36.84 5.06

Price Performance

Historical Comparison
COCP
BESS

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

About BESS Bimergen Energy Corporation Common Stock

Bimergen Energy Corp is a renewable energy project developer that enables the clean energy transition and provides critical grid stability via solutions across a range of applications through portfolio of utility-scale Battery Energy Storage System (BESS) and solar development projects. Its portfolio includes approximately 23 development-stage utility-scale BESS projects with a projected total storage capacity of around 1.965 gigawatts (GW) and approximately 13 development-stage solar energy projects expected to generate around 1.640 GW upon completion and operation.

Share on Social Networks: